Lyxor Index Fund - Lyxor Stoxx Europe 600 Chemicals UCITS ETF (LYX4.MU) is an exchange-traded fund that seeks to track the performance of the STOXX Europe 600 Chemicals index, which comprises the largest companies in the European chemicals sector within the STOXX Europe 600 universe; the ETF employs synthetic replication via an unfunded swap with Société Générale as counterparty, accumulates dividends for reinvestment, and maintains a total expense ratio of 0.30% p.a. Launched on August 25, 2006, and domiciled in France with assets under management of approximately EUR 12 million, the fund provides long-only exposure to European equities in the basic materials industry, focusing on chemicals subsector firms across countries including Germany, France, the UK, and others in the STOXX Europe 600 region. The fund, originally issued under Lyxor Asset Management—a pioneer in European ETFs founded in 1998 as a subsidiary of Société Générale and headquartered in Paris La Défense—now operates under Amundi ETF following Amundi's acquisition of Lyxor in 2021 for EUR 825 million and the effective merger of Lyxor entities into Amundi effective June 1, 2022. Recent developments include Amundi's ongoing rebranding and consolidation of Lyxor ETFs, such as mergers of other Lyxor commodity and broad-market products in 2024 to enhance economies of scale and reduce costs, though no specific merger or termination has been announced for this Chemicals ETF as of late 2025; the fund continues to list on exchanges including XETRA, Euronext Paris, and Borsa Italiana with Société Générale administering key functions.